ACUTE ISCHEMIC AND DELAYED ISCHEMIC NEUROLOGICAL DEFICITS AS THE CAUSES OF BAD GRADING IN ANEURYSMAL SUBARACHNOID HEMORRHAGE

被引:0
|
作者
SANO, K
机构
[1] UNIV TOKYO,DEPT NEUROSURG,TOKYO,TOKYO,JAPAN
[2] TEIKYO UNIV,DEPT NEUROSURG,TOKYO,TOKYO,JAPAN
[3] FUJI BRAIN INST,DEPT NEUROSURG,FUJI,SHIZUOKA,JAPAN
关键词
SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; INTRACRANIAL PRESSURE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
When subarachnoid haemorrhage (SAH) occurs, intracranial pressure (ICP) rises which heralds a series of symptoms termed acute ischaemic neurological deficits (AINDs). At the same time, free radicals are generated, and because of deficient scavenging mechanisms in the cerebrospinal fluid (CSF), these free radicals cause lipid peroxidation. Products of lipid peroxidation effect the cerebral arterial wall from the very early stage, probably infiltrating the wall through channels of the wall opening to the CSF space to exhibit inflammatory changes such as subintimal cell proliferation, myonecrosis etc. Lipid peroxidation also leads to degradation of membrane phospholipids, such as phosphatidylcholine (PC) and phosphatidylethanolamine (PE) and to rise in the intracellular level of diacylglycerol (DAC), an intrinsic protein kinase C (PKC) activator. Subsequent release of free arachidonic acid from PC (and/or PE) stimulates the arachidonate cascade which generates various eicosanoids and free radicals contributing to inflammatory changes in the arterial wall. As the intracellular level of DAC is increased, the PKC system is more and more activated, resulting in the development of sustained smooth muscle contraction. This, together with inflammatory changes in the arterial wall, forms the full-fledged picture of delayed cerebral vasospasm, leading to delayed ischaemic neurological deficits (DINDs).
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [41] Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage?
    Dreier, JP
    Ebert, N
    Priller, J
    Megow, D
    Lindauer, U
    Klee, R
    Reuter, U
    Imai, Y
    Einhäupl, KM
    Victorov, I
    Dirnagl, U
    JOURNAL OF NEUROSURGERY, 2000, 93 (04) : 658 - 666
  • [42] Cortical infarcts in a primate model of subarachnoid hemorrhage (SAH):: Is it an animal model of delayed ischemic deficits?
    Schatlo, Bawarjan
    Vortmeyer, Alexander O.
    Glaesker, Sven
    Oldfield, Edward H.
    Dreier, Jens P.
    Pluta, Ryszard M.
    JOURNAL OF NEUROSURGERY, 2008, 108 (04) : A875 - A875
  • [43] Focal Neurological Deficit at Onset of Aneurysmal Subarachnoid Hemorrhage: Frequency and Causes
    Behrouz, Reza
    Birnbaum, Lee A.
    Jones, Pearl M.
    Hans, Christopher
    Misra, Vivek
    Rabinstein, Alejandro A.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (11): : 2644 - 2647
  • [44] Correlation Among Systemic Inflammatory Parameter, Occurrence of Delayed Neurological Deficits, and Outcome After Aneurysmal Subarachnoid Hemorrhage
    Muroi, Carl
    Hugelshofer, Michael
    Seule, Martin
    Tastan, Ilhan
    Fujioka, Masayuki
    Mishima, Kenichi
    Keller, Emanuela
    NEUROSURGERY, 2013, 72 (03) : 367 - 375
  • [45] SAFETY OF HYPERTENSIVE HYPERVOLEMIC THERAPY WITH PHENYLEPHRINE IN THE TREATMENT OF DELAYED ISCHEMIC DEFICITS AFTER SUBARACHNOID HEMORRHAGE
    MILLER, JA
    DACEY, RG
    DIRINGER, MN
    STROKE, 1995, 26 (12) : 2260 - 2266
  • [46] Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase Ii randomised placebo-controlled trial
    Tseng, MY
    Kirkpatrick, PJ
    Czosnyka, M
    Richards, H
    Pickard, JD
    CIRCULATION, 2005, 112 (17) : U475 - U476
  • [47] Concurrent Acute Ischemic Stroke and Non-Aneurysmal Subarachnoid Hemorrhage in COVID-19
    de Castillo, Lennie Lynn C.
    Diestro, Jose Danilo B.
    Ignacio, Katrina Hannah D.
    Separa, Karl Josef Nino J.
    Pasco, Paul Matthew D.
    Franks, Maria Carissa P.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2021, 48 (04) : 587 - 588
  • [48] RELATIONSHIP BETWEEN LEUKOCYTOSIS AND ISCHEMIC COMPLICATIONS FOLLOWING ANEURYSMAL SUBARACHNOID HEMORRHAGE
    SPALLONE, A
    ACQUI, M
    PASTORE, FS
    GUIDETTI, B
    SURGICAL NEUROLOGY, 1987, 27 (03): : 253 - 258
  • [49] ISCHEMIC STROKE IN ANEURYSMAL SUBARACHNOID HEMORRHAGE-FREQUENCY AND RISK FACTORS
    Popa, L.
    Petrescu, S.
    Nicolae, H.
    Gurgu, R.
    Panea, C.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 583 - 583
  • [50] Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial
    Tseng, Ming-Yuan
    Hutchinson, Peter J.
    Richards, Hugh K.
    Czosnvka, Marek
    Pickard, John D.
    Erber, Wendy N.
    Brown, Stephen
    Kirkpatrick, Peter J.
    JOURNAL OF NEUROSURGERY, 2009, 111 (01) : 171 - 180